GSK Cuts Stake In Consumer Healthcare Business Haleon, Raises Around $1B
Portfolio Pulse from Vandana Singh
GSK Plc has raised around $1.08 billion by selling some of its shares in Haleon Plc, reducing its stake to about 7.4%. Pfizer Inc, which holds a 32% stake in Haleon, also plans to reduce its ownership in the coming months. GSK's shares are up 0.58% while Haleon's shares are down 2.03%.
October 06, 2023 | 1:12 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
GSK has raised significant funds by selling its Haleon shares, which could be used for other strategic investments.
The sale of Haleon shares has provided GSK with significant funds, which could be used for other strategic investments. This could potentially boost GSK's stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEUTRAL IMPACT
Pfizer, which holds a 32% stake in Haleon, plans to reduce its ownership in the coming months.
Pfizer's announcement to reduce its stake in Haleon could potentially impact its stock in the short term, but the exact impact is uncertain at this point.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Haleon's stock has dropped following the sale of shares by GSK.
The sale of Haleon shares by GSK has led to a drop in Haleon's stock. This could potentially negatively impact Haleon's stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100